Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
This trial is a prospective non-interventional observational study. The Chinese patients with lymphoma were included and the study data on driver gene abnormalities, demographic characteristics, clinicopathological characteristics and treatment were collected to evaluate the relevance of efficacy and disease prognosis.
Study Type
OBSERVATIONAL
Enrollment
200
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Zhengzhou, Henan, China
RECRUITINGIncidence of driver gene abnormalities
the incidence of driver gene abnormalities by fixed gene testing technology
Time frame: from the day of the first patient was included to the date of the end of this trial, assessed up to 36 months
objective response rate
the total proportion of patients with complete response (CR) and partial response (PR)
Time frame: from the date of the first patient was included to the date of the end of this trial, assessed up to 36 months
5-year overall survival
from the date of first patient was included to the date of death by any cause
Time frame: from the date of the first patient was included to the date of the end of this trial, assessed up to 5 years
Clinicopathological Characteristics
study data on clinicopathological characteristics related to incidence of driver gene abnormalities
Time frame: from the date of the first patient was included to the date of the end of this trial, assessed up to 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.